SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-301480
Filing Date
2013-07-25
Accepted
2013-07-25 08:01:59
Documents
3
Period of Report
2013-07-19
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d573357d8k.htm 8-K 15197
2 EX-99.1 d573357dex991.htm EX-99.1 65031
3 GRAPHIC g573357lajolla.jpg GRAPHIC 5504
  Complete submission text file 0001193125-13-301480.txt   89134
Mailing Address 4370 LA JOLLA VILLAGE DR. SUITE 400 SAN DIEGO CA 92122
Business Address 4370 LA JOLLA VILLAGE DR. SUITE 400 SAN DIEGO CA 92122 858-452-6600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24274 | Film No.: 13985006
SIC: 2836 Biological Products, (No Diagnostic Substances)